Refractory Hepatocellular Carcinoma
6 clinical trials · Condition
◉ Watch Refractory Hepatocellular Carcinoma
| Record | Firm | Date |
|---|---|---|
| Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors (NCT04851119) | Children's Oncology Group | 2021-11-08 |
| Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors (NCT02867592) | National Cancer Institute (NCI) | 2017-05-18 |
Track Refractory Hepatocellular Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.